%0 Journal Article
%T Comparative Diagnostic Performance of ⁶⁸Ga-PSMA and ⁶⁸Ga-DOTA-RM2 PET/MRI in the Evaluation of Recurrent Prostate Cancer
%A Tien Yin Wong
%A Joseph J. Y. Sung
%A Joseph Lau
%A Paul K. S. Chan
%J Asian Journal of Current Research in Clinical Cancer
%@ 3062-4444
%D 2023
%V 3
%N 1
%R 10.51847/Ibu5Dgs8Wp
%P 105-119
%X This investigation compares how effectively 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI identify prostate cancer (PCa) recurrence following initial therapy and examines how the results of these two tracers relate to clinical and pathological variables. Thirty-five men experiencing biochemical relapse (BCR) underwent restaging with 68Ga-PSMA PET/MRI, and 31 of them also completed a 68Ga-DOTA-RM2 PET/MRI examination within a period of up to 16 days (mean interval: 3 days; range: 2–16 days). Imaging obtained from both modalities was assessed qualitatively and quantitatively at the patient and lesion levels, and findings were verified through clinical evaluation and subsequent diagnostic follow-up. Statistical analyses were performed using Fisher’s exact test and the Mann-Whitney U test, adopting a p-value threshold of 
%U https://galaxypub.co/article/comparative-diagnostic-performance-of-68ga-psma-and-68ga-dota-rm2-petmri-in-the-evaluation-of-recur-wvhjlflubswom99